This Article Full Text Full Text (PDF) All Versions of this Article: jhc.5A6881.2006v1 54/8/889    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zeng, H. Articles by Li, E. Search for Related Content PubMed PubMed Citation Articles by Zeng, H. Articles by Li, E. Social Bookmarking                      What's this?

Altered Expression of Ezrin in Esophageal Squamous Cell Carcinoma

Hongmei Zeng¹, Liyan Xu¹, Dawei Xiao, Haihua Zhang, Xianying Wu, Ruiming Zheng, Qiaoshan Li, Yongdong Niu, Zhongying Shen and Enmin Li

Department of Biochemistry and Molecular Biology (HZ,HZ,YN,EL) and Department of Pathology (LX,XW,RZ,QL,ZS), Medical College of Shantou University, Shantou, Guangdong Province, People's Republic of China; Institute of Virology and Pharmacology, College of Life Science and Bioengineering, Beijing University of Technology, Beijing, People's Republic of China (LX); and Department of Cardiothoracic Surgery, The First Affiliated Hospital of Shantou University, Shantou, Guangdong Province, People's Republic of China (DX)

Correspondence to: Enmin Li, Department of Biochemistry and Molecular Biology, Medical College of Shantou University, 22 Xinling Road, Shantou City, Guangdong Province, P.R. China. E-mail: nmli{at}stu.edu.cn

Ezrin is a membrane–cytoskeletal linker belonging to the ezrin–radixin–moesin (ERM) family and has been suggested to be involved in tumorigenesis. In this study we investigated ezrin expression pattern in normal esophageal mucosa and esophageal squamous cell carcinoma (ESCC) and the correlation with clinical characteristics. Immunohistochemical staining showed a tendency for ezrin to translocate from membrane to cytoplasm in the progression from normal epithelium to invasive carcinoma of the esophagus. By Western blot, we found that ezrin expression was downregulated in 13 ESCC specimens and upregulated in 36 others. Moreover, quantitative real-time RT-PCR demonstrated that ezrin mRNA level in normal esophageal mucosa was 3.60 ± 3.60 times that in ESCC (p<0.001). Proliferating cell nuclear antigen (PCNA) expression level was higher in ezrin downregulated group compared with that in ezrin upregulated group (p<0.05). However, there was no significant association between ezrin expression and clinical characteristics. The results suggested that the localization of ezrin by immunohistochemistry may be useful in the diagnosis of ESCC, and ezrin may play a suppressive role in the tumorgenesis of ESCC. (J Histochem Cytochem 54:889–896, 2006)

Key Words: esophageal carcinoma • ezrin • immunohistochemistry • real-time RT-PCR • proliferating cell nuclear antigen

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-Y. Gao, E.-M. Li, L. Cui, X.-F. Lu, L.-Y. Meng, H.-M. Yuan, J.-J. Xie, Z.-P. Du, J.-X. Pang, and L.-Y. Xu Sp1 and AP-1 Regulate Expression of the Human Gene VIL2 in Esophageal Carcinoma Cells J. Biol. Chem., March 20, 2009; 284(12): 7995 - 8004. [Abstract] [Full Text] [PDF]

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact

The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2006